SG5989G - 2-oxo-imidazolidine compounds,a process for preparing the same and a pharmaceutical composition - Google Patents

2-oxo-imidazolidine compounds,a process for preparing the same and a pharmaceutical composition

Info

Publication number
SG5989G
SG5989G SG59/89A SG5989A SG5989G SG 5989 G SG5989 G SG 5989G SG 59/89 A SG59/89 A SG 59/89A SG 5989 A SG5989 A SG 5989A SG 5989 G SG5989 G SG 5989G
Authority
SG
Singapore
Prior art keywords
oxo
preparing
pharmaceutical composition
same
imidazolidine compounds
Prior art date
Application number
SG59/89A
Other languages
English (en)
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG5989G publication Critical patent/SG5989G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG59/89A 1982-05-24 1989-02-03 2-oxo-imidazolidine compounds,a process for preparing the same and a pharmaceutical composition SG5989G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57088637A JPS6058233B2 (ja) 1982-05-24 1982-05-24 ２−オキソイミダゾリジン誘導体及びその製法

Publications (1)

Publication Number Publication Date
SG5989G true SG5989G (en) 1989-06-09

Family

ID=13948325

Family Applications (1)

Application Number Title Priority Date Filing Date
SG59/89A SG5989G (en) 1982-05-24 1989-02-03 2-oxo-imidazolidine compounds,a process for preparing the same and a pharmaceutical composition

Country Status (8)

Country Link
US (1) US4508727A (de)
EP (1) EP0095163B1 (de)
JP (1) JPS6058233B2 (de)
DE (2) DE3373100D1 (de)
ES (2) ES522678A0 (de)
HK (1) HK32689A (de)
MY (1) MY100095A (de)
SG (1) SG5989G (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61293538A (ja) * 1985-06-24 1986-12-24 Shinto Paint Co Ltd 固体または半固体溶質の溶媒による溶解方法
KR930004646B1 (ko) * 1986-12-09 1993-06-02 다나베 세이야꾸 가부시끼가이샤 심기능 부전의 예방 및 치료제
EP0272849B1 (de) * 1986-12-12 1992-10-14 Tanabe Seiyaku Co., Ltd. Verwendung von 2-Oxo-imidazolidin-Derivaten zur Behandlung von Nierenkrankheiten
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
JPH066833Y2 (ja) * 1988-05-17 1994-02-23 川澄化学工業株式会社 輸液バッグ
JPH0645603B2 (ja) * 1988-12-16 1994-06-15 田辺製薬株式会社 光学活性２‐オキソイミダゾリジン誘導体の製法
JPH07121916B2 (ja) * 1993-12-10 1995-12-25 田辺製薬株式会社 光学活性３−アシル−２−オキソイミダゾリジン−４−カルボン酸誘導体及びその製法
MXPA05001958A (es) 2002-08-19 2005-04-28 Pfizer Prod Inc Terapia de combinacion para enfermedades hiperproliferativas.
CL2004000366A1 (es) * 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
JP4780437B2 (ja) * 2004-12-08 2011-09-28 大原薬品工業株式会社 ２−オキソイミダゾリジン誘導体の製造方法
JP4799085B2 (ja) * 2005-09-02 2011-10-19 株式会社カネカ 光学活性ｎ置換アミノアシル環状尿素誘導体の製造法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
JP5206926B2 (ja) * 2007-07-30 2013-06-12 株式会社Ｄｎｐファインケミカル宇都宮 塩酸イミダプリルの製造方法
MX2014002163A (es) 2011-08-26 2014-09-25 Wockhardt Ltd Métodos para el tratamiento de desórdenes cardiovasculares.
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
CN104119424B (zh) * 2014-07-01 2018-12-18 上海天慈生物谷生物工程有限公司 (4s)-3-[(2s)-2[(1s)-1-乙氧羰基-3-苯丙基]氨基丙酰基]-1-甲基-2-氧代咪唑啉-4-羧酸的制备方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN105713068B (zh) * 2014-12-04 2021-04-20 湖南九典制药股份有限公司 一种制备咪达普利关键中间体及其衍生物的方法
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0048159A3 (de) * 1980-09-17 1982-05-12 University Of Miami Carboxyalkyl-Peptide und Thioäther und Äther von Peptiden als antihypertensive Mittel
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
JPS5835114A (ja) * 1981-08-21 1983-03-01 ザ・ユニバ−シイテイ・オブ・マイアミ 抗高血圧剤

Also Published As

Publication number Publication date
EP0095163A3 (en) 1984-09-12
MY100095A (en) 1989-10-10
ES535980A0 (es) 1985-12-16
JPS6058233B2 (ja) 1985-12-19
EP0095163A2 (de) 1983-11-30
ES8603427A1 (es) 1985-12-16
ES8503667A1 (es) 1985-03-16
JPS58203971A (ja) 1983-11-28
DE19975013I1 (de) 2003-09-04
US4508727A (en) 1985-04-02
DE3373100D1 (en) 1987-09-24
HK32689A (en) 1989-04-28
EP0095163B1 (de) 1987-08-19
ES522678A0 (es) 1985-03-16

Similar Documents

Publication Publication Date Title
DE3373100D1 (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition
ZA83726B (en) Fibrinogen formulations,a process for its preparation and its use
DE3377795D1 (en) Spergualin-related compounds, processes for the preparation thereof and their use as medicaments
PT75472A (en) Process for preparing novel imidazoquinazoline derivativesand pharmaceutical compositions containing the same
EP0110397A3 (en) Polyprenyl compound, process for the production thereof and drug containing the same
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
ZA832226B (en) Penicillins,a process for the preparation and compositions containing them
ZA83231B (en) Process for the preparation of -caprolactone
DE3071707D1 (en) 7-n-heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same
DE3275087D1 (en) Benzamide derivatives, a process for preparing the same, and pharmaceutical compositions containing the same
GR80474B (en) Chinazolinderivatives, method for the preparation thereof, and medicaments containing said compounds
ZA831778B (en) Phenoxypropyltriazolyl-ketones and-carbinols,a process for their preparation,and their use as fungicides
ZA833981B (en) Noroxymorphone compounds,process for preparing such,and pharmaceutical compositions thereof
DE3471931D1 (en) Novel quinazolinone derivative, a process for preparing the same and a pharmaceutical composition
DE3479656D1 (en) Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same
DE3568041D1 (en) Sulfonamidines, a process for preparing them and pharmaceutical compositions containing them
DE3368046D1 (en) Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
EG16845A (en) New azapicyclic compounds and a process for the preparation thereof
RO86358B1 (ro) Procedeu pentru prepararea unor 1, 2, 4-triazol-1-il-propionitrili
ZA815988B (en) Aminoacid derivatives,a process for their preparation,agents containing these compounds,and the use thereof
DK170283A (da) Vaeskeseparator
ZA818689B (en) Imidazole derivatives,a process for the preparation thereof and a pharmaceutical composition containing them
DE3264768D1 (en) Novel heptadecapeptide, a method for its preparation and a pharmaceutical composition containing the same
DE3562370D1 (en) Amide compounds, process for preparing the same and pharmaceutical compositions containing the same
ZA826528B (en) Ascochlorin derivatives,process for preparing the same and pharmaceutical composition containing the same